Pharmacist Suspended, New Dispensing Guidelines Issued in Rajasthan Amid Cough Syrup Row

Published On 2025-10-04 10:34 GMT | Update On 2025-10-04 10:34 GMT

Jaipur: The cough syrup controversy in Rajasthan has now led to suspensions and sweeping new guidelines, as the health department cracked down on lapses following the deaths of children allegedly linked to dextromethorphan hydrobromide syrup. The state government suspended a pharmacist and a doctor of Hathideh PHC in Ajitgarh block, Sikar, for allegedly prescribing the syrup to a child, despite the drug not being recommended for children under four.

According to a recent media report in the Times of India, Director of Public Health Dr Ravi Prakash Sharma confirmed the disciplinary action and announced fresh directives for medical staff. The guidelines stress that no medicine can be dispensed without a valid prescription, and doctors must refrain from prescribing dextromethorphan syrups to children. Patients too have been warned against self-medication, with officials highlighting that unregulated use of the syrup can be dangerous.

Also Read: Probe Launched Against Rajasthan Pharma Firm Over Dextromethorphan Syrup-Linked Death

The controversy escalated after multiple cases were reported across Rajasthan. While fatalities in Sikar and Bharatpur drew attention, the health department clarified that not all cases resulted in death. In one instance, three-year-old Gagan, son of Monu Joshi from Bharatpur, developed cough and fever and was given the syrup by his father without prescription. He later fell ill but recovered after hospital treatment and was discharged, underscoring the risks of unsupervised use, reports Times of India

Also Read: Odisha: Huge cache of banned cough syrups seized, 3 arrested

Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Parthika Patel

Parthika Patel has completed her Graduated B.Pharm from SSR COLLEGE OF PHARMACY and done M.Pharm in Pharmaceutics. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Pharmacist Suspended, New Dispensing Guidelines Issued in Rajasthan Amid Cough Syrup Row

Similar News

CDSCO Flags MSD Pharma's Cancer Drug Trial Over Indian Representation, Control Arm

DoP Notifies Rs 5000 Cr PRIP Scheme to Boost Pharma, MedTech R&D

CDSCO panel nod to Bajaj Healthcare for Phase III clinical trials of insomnia drug Suvorexant

Cough Syrup crisis: Rajasthan govt suspends drug controller, halts distribution of Kaysons Pharma medicines

AstraZeneca Pharma India gains CDSCO permission for Enhertu in HER2-positive solid tumours

Lupin unveils Liraglutide Injection in US for diabetes

Police Have No Jurisdiction to Register FIR Under Drugs & Cosmetics Act: Delhi HC